# US 2015/0174042 A1 · Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0174042 A1
- Document ID: US20150174042A1
- Status: Published application
- Kind: A1
- Application number: 14/405,897
- Filed: 2013-06-07
- Published: 2015-06-25
- Earliest claimed: 2012-06-08
- Assignees: Vivatech Company; Centre National de la Recherche Scientifique (CNRS); Ecole Superieure De Physique Et Chimie Industrielles De La Ville De Paris
- Applicants: Vivatech; Centre National de la Recherche Scientifique-CNRS; Ecole Superieure de Physique et Chimie Industrielles de la Ville de Paris
- Inventors: Ludwik Leibler; Francois Tournilhac; Aggeliki Triftaridou; Eva-Maria Leuschner; Stephane Auguste; Jean-Marc Pernot
- Web page: https://patentgrep.com/patent/US20150174042A1

## CPC

- C08F 265/06: Polymerisation of acrylate or methacrylate esters on to polymers thereof
- A61K 8/0279: {Porous; Hollow}
- A61K 8/37: Esters of carboxylic acids
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/8147: {Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers}
- A61K 8/8152: {Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers}
- A61K 9/10: Dispersions; Emulsions
- A61K 9/7015: {Drug-containing film-forming compositions, e.g. spray-on}
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/12: Keratolytics, e.g. wart or anti-corn preparations
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61P 23/02: Local anaesthetics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61P 31/12: Antivirals
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- C08J 5/18: Manufacture of films or sheets
- C08L 33/08: Homopolymers or copolymers of acrylic acid esters
- C08L 33/12: Homopolymers or copolymers of methyl methacrylate
- C08L 101/12: characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity (liquid crystal materials or compositions C09K19/00)
- A61K 2800/413: Nanosized, i.e. having sizes below 100 nm
- A61K 2800/56: Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
- C08J 2300/12: Polymers characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
- C08J 2400/12: Polymers characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
- C08L 2207/02: Heterophasic composition
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention concerns an aqueous dispersion of multiphase polymer particles in which the polymer particles comprise at least two separate phases, the internal phase being formed by polymerisation in the presence of a crosslinking agent, said dispersion further comprising a surfactant chosen from amino acid derivatives. The invention also concerns a film-forming composition comprising said aqueous dispersion of polymer particles. The invention also relates to a film obtained after application of said film-forming composition. This film dries very quickly, is water resistant, and has good adhesion, elasticity and breaking strength properties. The invention also concerns the use of said film for protecting surfaces of the skin or mucous membranes, wounds, injuries and/or skin disorders.

## Claims

### Claim 1

An aqueous dispersion of multiphase polymer particles in which the polymer particles comprise at least two distinct phases:
a first phase formed by a polymer P1 of soft nature having a glass transition temperature (Tg1) of less than 20° C.,
a second phase formed by a polymer P2 of hard nature having a glass transition temperature (Tg2) of greater than 60° C.,
said dispersion comprising a surfactant chosen from amino acid derivatives and in which polymer P1 is formed by polymerization in the presence of a crosslinking agent.

### Claim 2 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein the phase formed by polymer P1 of soft nature is the internal phase of the particle and the phase formed by polymer P2 of hard nature is the external phase of the particle.

### Claim 3 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein the multiphase polymer particles are substantially spherical and exhibit a diameter of between 15 and 300 nanometers.

### Claim 4 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein polymer P1 represents from 60% to 90% by weight of the particles and polymer P2 represents from 10% to 40% by weight of the particles.

### Claim 5 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein polymer P1 comprises:
from 90% to 99.5% by weight of units obtained by polymerization of at least one monomer chosen from group (I) comprising (C1-C16)alkyl esters of (meth)acrylic acid, hydroxyalkyl esters of (meth)acrylic acid, vinyl esters of linear or branched carboxylic acids, styrene, alkylstyrenes, haloalkylstyrenes, (meth)acrylamide, acrylonitrile, vinyl chloride, (meth)acrylic acids and their derivatives, monomers comprising acidic or basic functional groups, silanated (meth)acrylic or vinyl monomers, monomers comprising acetoacetoxy groups, and mixtures thereof; and
from 0.5% to 10% by weight of units obtained by polymerization of a crosslinking agent.

### Claim 6 (depends on 5)

The aqueous dispersion as claimed in claim 5, wherein the crosslinking agent is chosen from group (II) comprising allyl or (C1-C16)alkyl esters of monocarboxylic or dicarboxylic acids, conjugated dienes, polyol poly(meth)acrylates, polyvinylbenzenes, polyallyl derivatives, and mixtures thereof.

### Claim 7 (depends on 1, 5)

The aqueous dispersion as claimed in claim 1, wherein polymer P2 comprises from 95% to 99.5% by weight of units obtained by polymerization of at least one monomer chosen from group (I) as defined in claim 5.

### Claim 8 (depends on 5)

The aqueous dispersion as claimed in claim 5, wherein the monomers of group (I) of polymer P1 are chosen from butyl acrylate, methyl methacrylate and mixtures thereof.

### Claim 9 (depends on 6)

The aqueous dispersion as claimed in claim 6, wherein the crosslinking agents of group (II) of polymer P1 are chosen from diallyl maleate, dimethyl maleate, 1,4-butanediol diacrylate and mixtures thereof.

### Claim 10 (depends on 7)

The aqueous dispersion as claimed in claim 7, wherein the monomer of group (I) of polymer P2 is methyl methacrylate.

### Claim 11 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein polymer P2 comprises at least 91% by weight of units obtained by polymerization of hydrophobic monomers.

### Claim 12 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein the surfactant derived from amino acids is chosen from sarcosinic acid derivatives and glutamic acid derivatives.

### Claim 13 (depends on 12)

The aqueous dispersion as claimed in claim 12, wherein the surfactant derived from amino acids is chosen from sodium N-lauroylglutamate, disodium N-cocoylglutamate, sodium N-cocoylglutamate, sodium N-lauroylsarcosinate, sodium N-myristoylsarcosinate, sodium N-cocoylsarcosinate, sodium N-oleoylsarcosinate, ammonium N-lauroylsarcosinate and mixtures thereof.

### Claim 14 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein the concentration of the surfactant is between 0.1% and 5% by weight, based on the weight of dry matter of the aqueous dispersion.

### Claim 15 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein the pH of the aqueous dispersion is greater than one unit above the pKa of the surfactant used.

### Claim 16 (depends on 1)

The aqueous dispersion as claimed in claim 1, wherein it comprises an active agent chosen from antibacterial agents, antiseptics, antivirals, antifungal agents, painkillers, anti-inflammatories, agents which promote healing, hydrating agents, depigmenting agents, keratolytic agents, restructuring agents, anesthetics and sunscreens.

### Claim 17 (depends on 16)

The aqueous dispersion as claimed in claim 16, wherein the active agent is incorporated in the internal phase or in the external phase of the multiphase polymer particles.

### Claim 18 (depends on 1)

A film-forming composition comprising a physiologically acceptable medium, an aqueous dispersion of multiphase polymer particles as claimed in claim 1.

### Claim 19 (depends on 18)

The film-forming composition as claimed in claim 18, wherein it comprises a pharmaceutical agent chosen from antibacterial agents, antiseptics, antivirals, antifungal agents, painkillers, anti-inflammatories, agents which promote healing, hydrating agents, depigmenting agents, keratolytic agents, restructuring agents, anesthetics and sunscreens.

### Claim 20

A film, characterized in that it exhibits at least two different Tg values, said film comprising multiphase polymer particles and a surfactant, in which the polymer particles comprise at least two distinct phases:
a first phase formed by a polymer P1 of soft nature having a glass transition temperature (Tg1) of less than 20° C.,
a second phase formed by a polymer P2 of hard nature having a glass transition temperature (Tg2) of greater than 60° C.,
in which said surfactant is chosen from amino acid derivatives and in which polymer P1 is formed by polymerization in the presence of a crosslinking agent.

### Claim 21 (depends on 18)

A process for protecting surfaces of the skin, mucous membranes, wounds, lesions and/or skin conditions comprising applying the film-forming composition as defined in claim 18 to the surface that is to be protected.
